PIH Announces Partnership To Tackle MDR-TB With New Drugs

Partners in Health: A New Partnership to Change MDR-TB Treatment around the World
Partners in Health announces that it has received a four-year, $60 million grant from UNITAID “to bring two new drugs to 17 countries in which MDR-TB [(multidrug-resistant tuberculosis)] poses a significant burden. Called ‘END-TB,’ this project is designed to dramatically expand access to these new drugs globally…” (6/10).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.